Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,487,479
+$608,669 QoQ
Shares Held
86,061
+2.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#144
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CIBC WORLD MARKET INC. holds $1,123,905,974 across 15 Drug Manufacturers - General names. NVS ranks #12 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
309,129 | $370,778,627 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,447,507 | $186,004,649 | |
| 3 | JNJ |
Johnson & Johnson
|
703,892 | $178,767,451 | |
| 4 | ABBV |
AbbVie Inc.
|
606,183 | $152,539,890 | |
| 5 | PFE |
Pfizer Inc
|
2,439,019 | $58,731,577 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
338,002 | $42,703,172 | |
| 7 | NVO |
Novo Nordisk A S
|
503,634 | $24,144,213 | |
| 8 | AMGN |
Amgen Inc
|
65,685 | $23,785,852 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,487,479 | 86,061 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,878,810 | 84,313 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $72,872,980 | 528,563 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $19,819,107 | 154,547 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $19,240,347 | 158,998 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $207,687,017 | 1,862,998 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,816,942 | 49,501 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $5,641,500 | 49,048 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,243,900 | 49,257 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,910,885 | 50,769 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,369,584 | 53,180 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,844,280 | 116,280 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,173,800 | 130,550 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $11,954,112 | 129,936 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,936,756 | 131,578 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,997,139 | 131,524 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $11,443,333 | 135,376 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $11,983,491 | 136,564 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $13,003,027 | 148,657 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,137,787 | 148,420 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,625,599 | 149,338 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $12,340,149 | 144,363 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $13,245,412 | 140,267 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $10,330,587 | 118,797 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,630,021 | 110,259 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,722,055 | 105,786 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||